Franya Hutchins1,2, Joshua Thorpe3,4, Matthew L Maciejewski5,6, Xinhua Zhao3, Karin Daniels3,7, Hongwei Zhang3, Donna M Zulman8,9, Stephan Fihn10, Sandeep Vijan11,12, Ann-Marie Rosland3,7. 1. Center for Health Equity Research and Promotion, VA Pittsburgh Health Care System, University Drive (151C), Pittsburgh, PA, 15240, USA. Franya.Hutchins@va.gov. 2. Caring for Complex Chronic Conditions Research Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Franya.Hutchins@va.gov. 3. Center for Health Equity Research and Promotion, VA Pittsburgh Health Care System, University Drive (151C), Pittsburgh, PA, 15240, USA. 4. Division of Pharmaceutical Outcomes & Policy, Eshelman School of Pharmacy, University of North Carolina - Chapel Hill, Chapel Hill, NC, USA. 5. Department of Population Health Sciences, Duke University Medical Center, Durham, NC, USA. 6. Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Medical Center, Durham, NC, USA. 7. Caring for Complex Chronic Conditions Research Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 8. Division of Primary Care and Population Health, Stanford University School of Medicine, Stanford, CA, USA. 9. Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, CA, USA. 10. Division of General Internal Medicine, University of Washington School of Medicine, Seattle, WA, USA. 11. VA Center for Clinical Management Research, Ann Arbor, MI, USA. 12. Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA.
Abstract
BACKGROUND: The ability of latent class models to identify clinically distinct groups among high-risk patients has been demonstrated, but it is unclear how healthcare data can inform group-specific intervention design. OBJECTIVE: Examine how utilization patterns across latent groups of high-risk patients provide actionable information to guide group-specific intervention design. DESIGN: Cohort study using data from 2012 to 2015. PATIENTS: Participants were 934,787 patients receiving primary care in the Veterans Health Administration, with predicted probability of 12-month hospitalization in the top 10th percentile during 2014. MAIN MEASURES: Patients were assigned to latent groups via mixture-item response theory models based on 28 chronic conditions. We modeled odds of all-cause mortality, hospitalizations, and 30-day re-hospitalizations by group membership. Detailed outpatient and inpatient utilization patterns were compared between groups. KEY RESULTS: A total of 764,257 (81.8%) of patients were matched with a comorbidity group. Groups were characterized by substance use disorders (14.0% of patients assigned), cardiometabolic conditions (25.7%), mental health conditions (17.6%), pain/arthritis (19.1%), cancer (15.3%), and liver disease (8.3%). One-year mortality ranged from 2.7% in the Mental Health group to 14.9% in the Cancer group, compared to 8.5% overall. In adjusted models, group assignment predicted significantly different odds of each outcome. Groups differed in their utilization of multiple types of care. For example, patients in the Pain group had the highest utilization of in-person primary care, with a mean (SD) of 5.3 (5.0) visits in the year of follow-up, while the Substance Use Disorder group had the lowest, with 3.9 (4.1) visits. The Substance Use Disorder group also had the highest rates of using services for housing instability (25.1%), followed by the Liver group (10.1%). CONCLUSIONS: Latent groups of high-risk patients had distinct hospitalization and utilization profiles, despite having comparable levels of predicted baseline risk. Utilization profiles pointed towards system-specific care needs that could inform tailored interventions.
BACKGROUND: The ability of latent class models to identify clinically distinct groups among high-risk patients has been demonstrated, but it is unclear how healthcare data can inform group-specific intervention design. OBJECTIVE: Examine how utilization patterns across latent groups of high-risk patients provide actionable information to guide group-specific intervention design. DESIGN: Cohort study using data from 2012 to 2015. PATIENTS: Participants were 934,787 patients receiving primary care in the Veterans Health Administration, with predicted probability of 12-month hospitalization in the top 10th percentile during 2014. MAIN MEASURES: Patients were assigned to latent groups via mixture-item response theory models based on 28 chronic conditions. We modeled odds of all-cause mortality, hospitalizations, and 30-day re-hospitalizations by group membership. Detailed outpatient and inpatient utilization patterns were compared between groups. KEY RESULTS: A total of 764,257 (81.8%) of patients were matched with a comorbidity group. Groups were characterized by substance use disorders (14.0% of patients assigned), cardiometabolic conditions (25.7%), mental health conditions (17.6%), pain/arthritis (19.1%), cancer (15.3%), and liver disease (8.3%). One-year mortality ranged from 2.7% in the Mental Health group to 14.9% in the Cancer group, compared to 8.5% overall. In adjusted models, group assignment predicted significantly different odds of each outcome. Groups differed in their utilization of multiple types of care. For example, patients in the Pain group had the highest utilization of in-person primary care, with a mean (SD) of 5.3 (5.0) visits in the year of follow-up, while the Substance Use Disorder group had the lowest, with 3.9 (4.1) visits. The Substance Use Disorder group also had the highest rates of using services for housing instability (25.1%), followed by the Liver group (10.1%). CONCLUSIONS: Latent groups of high-risk patients had distinct hospitalization and utilization profiles, despite having comparable levels of predicted baseline risk. Utilization profiles pointed towards system-specific care needs that could inform tailored interventions.
Authors: Li Wang; Brian Porter; Charles Maynard; Ginger Evans; Christopher Bryson; Haili Sun; Indra Gupta; Elliott Lowy; Mary McDonell; Kathleen Frisbee; Christopher Nielson; Fred Kirkland; Stephan D Fihn Journal: Med Care Date: 2013-04 Impact factor: 2.983
Authors: Kristin M Mattocks; Aimee Kroll-Desrosiers; Rebecca Kinney; Anashua R Elwy; Kristin J Cunningham; Michelle A Mengeling Journal: Med Care Date: 2021-06-01 Impact factor: 2.983
Authors: Richard W Grant; Jodi McCloskey; Meghan Hatfield; Connie Uratsu; James D Ralston; Elizabeth Bayliss; Chris J Kennedy Journal: JAMA Netw Open Date: 2020-12-01
Authors: Anna C Davis; Ernest Shen; Nirav R Shah; Beth A Glenn; Ninez Ponce; Donatello Telesca; Michael K Gould; Jack Needleman Journal: J Gen Intern Med Date: 2018-09-04 Impact factor: 6.473